shire map
Select a
Location

Shire Global

Newsroom

Director Declaration

April 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Susan Kilsby, Chairman of the Company, was appointed as a Non-Executive Director of Diageo plc on April 4, 2018.

This disclosure is made pursuant to LR 9.6.14 of the UK Listing Rules.

Oliver Strawbridge
Senior Assistant Company Secretary

For further information please contact:


Investor Relations  
Christoph Brackmannchristoph.brackmann@shire.com+41 795 432 359
Robert Coatesrcoates@shire.com+44 203 549 0874
Sun Kimsun.kim@shire.com+1 617 588 8175
Media  
Katie Joycekjoyce@shire.com+1 781 482 2779

NOTES TO EDITORS

About Shire

Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.

We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.

www.shire.com

Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE